VICTORY CAPITAL MANAGEMENT INC - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$421,699
-71.5%
10,223
-61.4%
0.00%
-100.0%
Q2 2023$1,478,866
-4.4%
26,484
-4.5%
0.00%0.0%
Q1 2023$1,546,778
+337.2%
27,725
+185.6%
0.00%
Q4 2022$353,760
+27.7%
9,708
-0.1%
0.00%
Q3 2022$277,000
-92.1%
9,713
-58.8%
0.00%
-100.0%
Q4 2021$3,509,000
-46.5%
23,560
-47.7%
0.00%
-50.0%
Q3 2021$6,554,000
-37.6%
45,015
-16.0%
0.01%
-40.0%
Q2 2021$10,496,000
-67.5%
53,599
-69.9%
0.01%
-69.7%
Q1 2021$32,263,000
+26.1%
178,251
-1.3%
0.03%
+17.9%
Q4 2020$25,578,000
+0.5%
180,632
-11.5%
0.03%
-15.2%
Q3 2020$25,461,000
+23.3%
204,216
-11.7%
0.03%
+17.9%
Q2 2020$20,654,000
-53.7%
231,269
-67.7%
0.03%
-26.3%
Q1 2020$44,650,000
+28.7%
716,478
+57.5%
0.04%
-9.5%
Q4 2019$34,686,000
+22.5%
454,894
-19.0%
0.04%
+16.7%
Q3 2019$28,308,000561,6740.04%
Other shareholders
10X GENOMICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,753,528$133,391,000100.00%
Foresite Capital Management I, LLC 750,000$57,053,00099.71%
12 West Capital Management LP 2,518,500$191,582,00011.65%
Meritech Capital Associates V L.L.C. 1,336,253$101,649,0009.59%
Blue Water Life Science Advisors, LP 211,917$16,121,0007.65%
Decheng Capital Management III (Cayman), LLC 303,984$23,124,0007.09%
FINANCIAL CONSULATE, INC 154,942$11,786,0004.53%
Evolutionary Tree Capital Management, LLC 54,128$4,118,0002.86%
HARVARD MANAGEMENT CO INC 186,143$14,160,0001.43%
Brown Capital Management 1,663,469$126,540,0001.26%
View complete list of 10X GENOMICS INC shareholders